Top

Published in:

01-11-2017 | ORIGINAL ARTICLE

Severe Hyperhomocysteinemia Decreases Creatine Kinase Activity and Causes Memory Impairment: Neuroprotective Role of Creatine

Authors: Janaína Kolling, Aline Longoni, Cassiana Siebert, Tiago Marcon dos Santos, Eduardo Peil Marques, Jaqueline Carletti, Lenir Orlandi Pereira, Angela T. S. Wyse

Published in: Neurotoxicity Research | Issue 4/2017

Abstract

In the present study, we investigate the effect of severe hyperhomocysteinemia on biochemical (creatine kinase activity), behavioral (memory tests), and histological assessments (hippocampal volume). A possible neuroprotective role of creatine on hyperhomocysteinemia effects was also evaluated. Severe hyperhomocysteinemia was induced in neonate rats (starting at 6 days of age) by treatment with homocysteine (0.3–0.6 μmol/g body weight) for 23 days. Creatine (50 mg/kg body weight) was administered concomitantly with homocysteine. Controls received saline in the same volumes. Twelve hours after the last injection, the rats were submitted to behavioral tests [(recognition task (NOR)] and inhibitory avoidance (IA)]. Following behavioral assessment, the animals were perfused and decapitated, the brain removed for subsequent morphological analysis of the hippocampus. Another group of animals was used to test creatine kinase activity in hippocampus. The results showed that rats treated with homocysteine decreased (44%) the exploration of the novel object in NOR. In the IA task, homocysteine-treated animals presented decreased latencies to step down the platform in short- (32%) and long-term (18%) testings (3 h and 7 days, respectively), evidencing aversive memory impairment. Hippocampal volume was not altered by homocysteine administration. Hyperhomocysteinemia decreased (45%) creatine kinase activity, and creatine was able to prevent such effect probably by creatine kinase/phosphocreatine/creatine homeostasis, which serves as energy circuit within of the cell. This finding may be associated, at least in part, with memory improvement, suggesting that creatine might represent an effective adjuvant to protect against the effects of high homocysteine plasma levels.

Adhihetty P, Beal M (2008) Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. NeuroMolecular Med 10(4):275–290. doi:10.1007/s12017-008-8053-y CrossRefPubMedPubMedCentral

Allen P (2012) Creatine metabolism and psychiatric disorders: does creatine supplementation have therapeutic value? Neurosci Biobehav Rev 36(5):1442–1462. doi:10.1016/j.neubiorev.2012.03.005 CrossRefPubMedPubMedCentral

Andres R, Ducray A, Schlattner U, Wallimann T, Widmer H (2008) Functions and effects of creatine in the central nervous system. Brain Res Bull 76(4):329–343. doi:10.1016/j.brainresbull.2008.02.035 CrossRefPubMed

Arteni N, Salgueiro J, Torres I, Achaval M, Netto C (2003) Neonatal cerebral hypoxia–ischemia causes lateralized memory impairments in the adult rat. Brain Res 973(2):171–178. doi:10.1016/s0006-8993(03)02436-3 CrossRefPubMed

Arteni N, Pereira L, Rodrigues A, Lavinsky D, Achaval M, Netto C (2010) Lateralized and sex-dependent behavioral and morphological effects of unilateral neonatal cerebral hypoxia-ischemia in the rat. Behav Brain Res 210(1):92–98. doi:10.1016/j.bbr.2010.02.015 CrossRefPubMed

Ataie A, Sabetkasaei M, Haghparast A, Moghaddam A, Ataee R, Moghaddam S (2010) Curcumin exerts neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain. J Med Food 13(4):821–826. doi:10.1089/jmf.2009.1278 CrossRefPubMed

Beal MF (2011) Neuroprotective effects of creatine. Amino Acids 40(5):1305–1313

Bender A, Klopstock T (2016) Creatine for neuroprotection in neurodegenerative disease: end of story? Amino Acids 48(8):1929–1940

Bender A, Samtleben W, Elstner M, Klopstock T (2008) Long-term creatine supplementation is safe in aged patients with Parkinson disease. Nutr Res 28(3):172–178. doi:10.1016/j.nutres.2008.01.001 CrossRefPubMed

Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M, Gekeler F, Muller-Myhsok B, Gasser T, Tatsch K, Klopstock T (2006) Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 67(7):1262–1264

Benice T, Raber J (2009) Dihydrotestosterone modulates spatial working-memory performance in male mice. J Neurochem 110(3):902–911. doi:10.1111/j.1471-4159.2009.06183.x CrossRefPubMed

Bhatia P, Singh N (2015) Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression. Fundam Clin Pharmacol 29(6):522–528. doi:10.1111/fcp.12145 CrossRefPubMed

Breckenridge D, Germain M, Mathai J, Nguyen M, Shore G (2003) Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22(53):8608–8618. doi:10.1038/sj.onc.1207108 CrossRefPubMed

Burbaeva GSh, Savushkina OK, Dmitriev AD (1999) Brain isoforms of creatine kinase in health and mental diseases: Alzheimer's disease and schizophrenia. Vestn Ross Akad Med Nauk (1):20–4

Chan A, Alsaraby A, Shea T (2008) Folate deprivation increases tau phosphorylation by homocysteine-induced calcium influx and by inhibition of phosphatase activity: alleviation by S-adenosyl methionine. Brain Res 1199:133–137. doi:10.1016/j.brainres.2008.01.008 CrossRefPubMed

Christie L, Riedel G, Algaidi S, Whalley L, Platt B (2005) Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine. Neurosci Lett 373(2):119–124CrossRefPubMed

Chung YC, Kruyer A, Yao Y, Feierman E, Richards A, Strickland S, Norris EH (2016) Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the Î²-amyloid fibrinogen interaction. J Thromb Haemost 14(7):1442–1452

Chung Y-l, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Ståhl-Hallengren C, Selwyn R, Louise Thomas E, Hamilton G, Bell JD, Lundberg IE, Scott DL (2007) Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 57(4):694–702

Clark R, Martin S (2005) Interrogating rodents regarding their object and spatial memory. Curr Opin Neurobiol 15(5):593–598. doi:10.1016/j.conb.2005.08.014 CrossRefPubMed

da Cunha AA, Ferreira AG, da Cunha MJ, Pederzolli CD, Becker DL, Coelho JG, Dutra-Filho CS, Wyse AT (2011) Chronic hyperhomocysteinemia induces oxidative damage in the rat lung. Mol Cell Biochem 358(1–2):153–160. doi:10.1007/s11010-011-0930-2 CrossRefPubMed

da Cunha A, Ferreira A, Loureiro S, da Cunha M, Schmitz F, Netto C, Wyse A (2012a) Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 37(8):1660–1669. doi:10.1007/s11064-012-0769-2 CrossRefPubMed

da Cunha AA, Scherer E, da Cunha MJ, Schmitz F, Machado FR, Lima DD, Delwing D, Wyse AT (2012b) Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats. Mol Cell Biochem 360(1–2):205–214. doi:10.1007/s11010-011-1058-0 CrossRefPubMed

Firbank MJ, Narayan SK, Saxby BK, Ford GA, O'Brien JT (2010) Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension. Int Psychogeriatr 22(05):804–811

Gasche Y, Fujimura M, Morita-Fujimura Y, Copin J, Kawase M, Massengale J, Chan P (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. Journal Of Cerebral Blood Flow & Metabolism 1020–1028

Gualano B, Lugaresi R, Painelli de Salles V, Queiroz A, Artioli G, Roschel H et al (2011) Creatine supplementation does not augment muscle carnosine content in type 2 diabetic patients. Appl Physiol Nutr Metab 36(5):764–767. doi:10.1139/h11-083 CrossRefPubMed

Gualano B, Roschel H, Lancha AH, Brightbill CE, Rawson ES (2012) In sickness and in health: the widespread application of creatine supplementation. Amino Acids 43(2):519–529. doi:10.1007/s00726-011-1132-7

Ho P, Ortiz D, Rogers E, Shea T (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70(5):694–702. doi:10.1002/jnr.10416 CrossRefPubMed

Hoyer S, Lannert H (2008) Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin. J Neural Transm 115(9):1241–1249. doi:10.1007/s00702-008-0079-7 CrossRefPubMed

Hughes B (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7(5):597–603. doi:10.1016/0009-8981(62)90137-7 CrossRefPubMed

Imbard A, Benoist JF, Esse R, Gupta S, Lebon S, de Vriese AS, de Baulny HO, Kruger W, Schiff M, Blom HJ (2015) High homocysteine induces betaine depletion. Biosci Rep 35(4). doi:10.1042/BSR20150094

Khan R, Hossain M, Nai Q, Yousif A, Sen S (2015) Hyperhomocysteinemia association with transient global amnesia: a rare case report. N Am J Med Sci 7(8):374. doi:10.4103/1947-2714.163647 CrossRefPubMedPubMedCentral

Kolling J, Wyse A (2010) Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration. Metab Brain Dis 25(3):331–338. doi:10.1007/s11011-010-9215-9 CrossRefPubMed

Kolling J, Scherer E, Siebert C, Hansen F, Torres F, Scaini G et al (2012) Homocysteine induces energy imbalance in rat skeletal muscle: is creatine a protector? Cell Biochem Funct. doi:10.1002/cbf.2938

Kolling J, Scherer EB, Siebert C, Marques EP, Dos Santos TM, Wyse AT (2014) Creatine prevents the imbalance of redox homeostasis caused by homocysteine in skeletal muscle of rats. Gene 545(1):72–9. doi: 10.1016/j.gene.2014.05.005

Kolling J, Scherer EB, Siebert C, Longoni A, Loureiro S, Weis S, Petenuzzo L, Wyse AT (2015) Severe hyperhomocysteinemia decreases respiratory enzyme and Na+−K+ ATPase activities, and leads to mitochondrial alterations in rat amygdala. Neurotox Res 29(3):408–418. doi:10.1007/s12640-015-9587-z

Kunisawa K, Nakashima N, Nagao M, Nomura T, Kinoshita S, Hiramatsu M (2015) Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex. Behav Brain Res 292:36–43. doi:10.1016/j.bbr.2015.06.004 CrossRefPubMed

Lawler JM, Barnes WS, Wu G, Song W, Demaree S (2002) Direct antioxidant properties of Creatine. Biochem Biophys Res Commun 290(1):47–52

Lee S, Lee Y, Seo K, Bae J, Kim G, Park S, Kim C (2012) Homocysteine enhances MMP-9 production in murine macrophages via ERK and Akt signaling pathways. Toxicol Appl Pharmacol 260(1):89–94. doi:10.1016/j.taap.2012.01.026 CrossRefPubMed

Machado F, Ferreira A, da Cunha A, Tagliari B, Mussulini B, Wofchuk S, Wyse A (2011) Homocysteine alters glutamate uptake and Na+,K+−ATPase activity and oxidative status in rats hippocampus: protection by vitamin C. Metab Brain Dis 26(1):61–67. doi:10.1007/s11011-011-9232-3 CrossRefPubMed

Matté C, Pereira L, Dos Santos T, Mackedanz V, Cunha A, Netto C, Wyse A (2009a) Acute homocysteine administration impairs memory consolidation on inhibitory avoidance task and decreases hippocampal brain-derived neurotrophic factor immunocontent: prevention by folic acid treatment. Neuroscience 163(4):1039–1045. doi:10.1016/j.neuroscience.2009.07.023 CrossRefPubMed

Matté C, Stefanello FM, Mackedanz V, Pederzolli CD, Lamers ML, Dutra-Filho CS, Dos Santos MF, Wyse AT (2009b) Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci 27(4):337–344. doi:10.1016/j.ijdevneu.2009.03.005 CrossRefPubMed

McCully KS (2015) Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol 8(2):211–219. doi:10.1586/17512433.2015.1010516 Review CrossRefPubMed

Miller AL (2003) The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 8(1):7–19PubMed

Netto C, Dias R, Izquierdo I (1985) Interaction between consecutive learnings: inhibitory avoidance and habituation. Behav Neural Biol 44(3):515–520. doi:10.1016/s0163-1047(85)91048-9 CrossRefPubMed

Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580(13):2994–3005. doi:10.1016/j.febslet.2006.04.088 CrossRefPubMed

Obeid R, McCaddon A, Herrmann W (2007) The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 45(12). doi:10.1515/cclm.2007.356

Okuda S, Roozendaal B, McGaugh J (2004) Glucocorticoid effects on object recognition memory require training-associated emotional arousal. Proc Natl Acad Sci 101(3):853–858. doi:10.1073/pnas.0307803100 CrossRefPubMedPubMedCentral

Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates 2ed. Academic Press, Sydney

Pereira L, Arteni N, Petersen R, da Rocha A, Achaval M, Netto C (2007) Effects of daily environmental enrichment on memory deficits and brain injury following neonatal hypoxia-ischemia in the rat. Neurobiol Learn Mem 87(1):101–108. doi:10.1016/j.nlm.2006.07.003 CrossRefPubMed

Rodrigues A, Arteni N, Abel C, Zylbersztejn D, Chazan R, Viola G et al (2004) Tactile stimulation and maternal separation prevent hippocampal damage in rats submitted to neonatal hypoxia–ischemia. Brain Res 1002(1–2):94–99. doi:10.1016/j.brainres.2003.12.020 CrossRefPubMed

Rodrigues AF, Biasibetti H, Zanotto BS, Sanches EF, Pierozan P, Schmitz F, Parisi MM, Barbé-Tuana F, Netto CA, Wyse ATS (2016) Intracerebroventricular d-galactose administration impairs memory and alters activity and expression of acetylcholinesterase in the rat. Int J Dev Neurosci 50:1–6

Sanches E, Arteni N, Scherer E, Kolling J, Nicola F, Willborn S et al (2013) Are the consequences of neonatal hypoxia–ischemia dependent on animals’ sex and brain lateralization? Brain Res 1507:105–114. doi:10.1016/j.brainres.2013.02.040 CrossRefPubMed

Seshadri S, Wolf P, Beiser A, Selhub J, Au R, Jacques P et al (2008) Association of plasma total homocysteine levels with subclinical brain injury. Arch Neurol 65(5). doi:10.1001/archneur.65.5.642

Sestili P, Chiara M, Bravi G, Piccoli G, Curci R, Battistelli M, Falcieri E, Agostini D, Gioacchini AM, Stocchi V (2006) Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40(5):837–849

Shimomura T, Futoshi A, Takayuki M, Umeno Y, Eshima N, Saikawa T, Yoshimatsu H, Fujiki M, Kobayashi H (2011) Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients. Eur J Clin Investig 41(7):751–758

Sørensen JT, Gaustadnes M, Stabler SP, Allen RH, Mudd SH, Hvas AM (2016) Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemia. Mol Genet Metab 117(3):344–350. doi:10.1016/j.ymgme.2015.12.010 CrossRefPubMed

Streck E, Zugno A, Tagliari B, Sarkis J, Wajner M, Wannmacher C, Wyse A (2002) On the mechanism of the inhibition of Na+, K+−ATPase activity caused by homocysteine. Int J Dev Neurosci 20(2):77–81. doi:10.1016/s0736-5748(02)00043-6 CrossRefPubMed

Streck EL, Delwing D, Tagliari B, Matté C, Wannmacher CM, Wajner M, Wyse AT (2003a) Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochem Int 43(6):597–602CrossRefPubMed

Streck EL, Matté C, Vieira PS, Calcagnotto T, Wannmacher CM, Wajner M, Wyse AT (2003b) Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia. Biochim Biophys Acta 1637(3):187–192CrossRefPubMed

Streck E, Bavaresco C, Netto C, Wyse A (2004) Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav Brain Res 153(2):377–381. doi:10.1016/j.bbr.2003.12.013 CrossRefPubMed

Suresh P, Ayyappan A, Nandini J, Ismail T (2015). Cognitive deficits and behavioral disorders in children: a comprehensive multidisciplinary approach to management. Annals of Behavioural Science

Tarnopolsky MA (2007) Clinical use of creatine in neuromuscular and neurometabolic disorders. Subcell Biochem 46:183–204

Vanzin CS, Manfredini V, Marinho AE, Biancini GB, Ribas GS, Deon M, Wyse AT, Wajner M, Vargas CR (2014) Homocysteine contribution to DNA damage in cystathionine β-synthase-deficient patients. Gene 539(2):270–274. doi:10.1016/j.gene.2014.02.015 CrossRefPubMed

Vanzin CS, Mescka CP, Donida B, Hammerschimidt TG, Ribas GS, Kolling J, Scherer EB, Vilarinho L, Nogueira C, Coitinho AS, Wajner M, Wyse AT, Vargas CR (2015) Lipid, oxidative and inflammatory profile and alterations in the enzymes paraoxonase and butyrylcholinesterase in plasma of patients with homocystinuria due CBS deficiency: the vitamin B12 and folic acid importance. Cell Mol Neurobiol 35(6):899–911. doi:10.1007/s10571-015-0185-7 CrossRefPubMed

Varga EA, Sturm AC, Misita CP, Moll S (2005) Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 111(19):e289–e293. doi:10.1161/01.cir.0000165142.37711.e7

Vasques V, Brinco F, Viegas C, Wajner M (2006) Creatine prevents behavioral alterations caused by methylmalonic acid administration into the hippocampus of rats in the open field task. J Neurol Sci 244(1–2):23–29. doi:10.1016/j.jns.2005.12.005 CrossRefPubMed

Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger H (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 281(1):21–40. doi:10.1042/bj2810021 CrossRefPubMedPubMedCentral

Watanabe A, Kato N, Kato T (2002) Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 42(4):279–285

Wyss M, Schulze A (2002) Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112(2):243–260. doi:10.1016/s0306-4522(02)00088-x CrossRefPubMed

Yang Y, Fann M, Chang W, Tai L, Jiang J, Kao L (2010) Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions. J Biol Chem 285(36):28275–28285. doi:10.1074/jbc.m110.141424 CrossRefPubMedPubMedCentral

Zhao H, Ji Z, Liu C, Yu X (2015) Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in rats. Neuroscience 290:485–491. doi:10.1016/j.neuroscience.2015.01.060 CrossRefPubMed

Zhang X-l, An L-j, Bao Y-m, Wang J-y, Jiang B (2008) D-galactose administration induces memory loss and energy metabolism disturbance in mice: protective effects of catalpol. Food Chem Toxicol 46(8):2888–2894

Title: Severe Hyperhomocysteinemia Decreases Creatine Kinase Activity and Causes Memory Impairment: Neuroprotective Role of Creatine
Authors: Janaína Kolling
Aline Longoni
Cassiana Siebert
Tiago Marcon dos Santos
Eduardo Peil Marques
Jaqueline Carletti
Lenir Orlandi Pereira
Angela T. S. Wyse
Publication date: 01-11-2017
Publisher: Springer US
Published in: Neurotoxicity Research / Issue 4/2017
Print ISSN: 1029-8428
Electronic ISSN: 1476-3524
DOI: https://doi.org/10.1007/s12640-017-9767-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Severe Hyperhomocysteinemia Decreases Creatine Kinase Activity and Causes Memory Impairment: Neuroprotective Role of Creatine

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Kanamycin Damages Early Postnatal, but Not Adult Spiral Ganglion Neurons

Epi/perineural and Schwann Cells as Well as Perineural Sheath Integrity are Affected Following 2,4-D Exposure

Lithium Chloride Facilitates Autophagy Following Spinal Cord Injury via ERK-dependent Pathway

Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications

Effects of Hydroxyurea Exposure on the Rat Cerebellar Neuroepithelium: an Immunohistochemical and Electron Microscopic Study Along the Anteroposterior and Mediolateral Axes

Gestational Age and Sex Influence the Susceptibility of Human Neural Progenitor Cells to Low Levels of MeHg